DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award

DOD-AMRAA Posted HT942526BCRPTBCCDA

Description

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Development Award provides successful applicants the time and resources needed to bring investigators and breast cancer consumer advocates together to establish a consortium framework and conduct preliminary research in support of an application to a future, full BCRP Transformative Breast Cancer Consortium Award (pending availability of funds). All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: · This is a development award and is a separate award mechanism from the full FY26 BCRP Transformative Breast Cancer Consortium Award (HT942526BCRPTBCCA). For FY26, investigators may be named as Consortium Director on an application submitted to either (but not both) of these award mechanisms. · Breast cancer consumer advocates must be active participants in the development and execution of the FY26 BCRP TBCCDA.
Actions
View on Grants.gov
Funding Details
Award Floor
Not specified
Award Ceiling
Not specified
Total Estimated Funding
$140,000.00
Expected Awards
1
Key Dates
Posted
May 4, 2026
Closes
July 8, 2026
Archive Date
August 7, 2026
Agency Information
Agency Name
Defense Health Agency Contracting Activity - DHACA
Agency Code
DOD-AMRAA
Funding Instrument
Other